Sandler Carl Forest Jr's Form 4 filing
Lunai Bioworks Inc. (LNAI) · filed Feb 23, 2022
- Accession no.
- 0001731122-22-000303
- Filed
- Feb 23, 2022
- Trade date
- Feb 18-23, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $61.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sandler Carl Forest JrCIK 0001734560 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2022 | Common Stock | SSaleDisposed | −6,792 | $9.03 | −$61,331.76 | 3,189,420 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −6 | $9.00 | −$54 | 3,189,414 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.